This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The purpose of this systematic review is to assess the evidence behind the dietary requirement of protein and to assess the health effects of varying protein intake in healthy elderly persons in order to evaluate the evidence for an optimal protein intake. The literature search covered year 2000–2011. Prospective cohort, case–control, and intervention studies of a general healthy population in settings similar to the Nordic countries with protein intake from food-based sources were included. Out of a total of 301 abstracts, 152 full papers were identified as potentially relevant. After careful scrutiny, 23 papers were quality graded as A (highest,
The present literature review is part of the fifth version of the Nordic Nutrition Recommendations (NNR5) project with the aim of reviewing and updating the scientific basis of the fourth edition of the NNR issued in 2004 (
In 2002, the Institute of Medicine (IoM) published the US dietary reference values for protein (
The meta-analysis by Rand et al. was also taken into account in the NNR4 protein requirement assessment. While the US recommendation was expressed as 0.83 g good-quality protein/kg body weight (BW)/day, the NNR4 recommendation was given as 10–20 energy percent (E%) from protein, which allowed for an overall macronutrient intake distribution, as well as adaptation to the Nordic dietary habits. The Nordic recommended protein intake of 10–20 E% was considered adequate to meet the requirement for protein, including essential amino acids for healthy elderly persons too.
In 2007, the WHO/FAO/UNU published their most recent recommendation on protein requirement (
Thus, until now, recommendations on protein requirements have been based on N-balance studies only. The recommendations of an optimal protein intake in relation to health outcomes are not clear. The present evidence on the relationship between protein intake and health outcomes has, however, not been based on systematic literature reviews.
The purpose of this systematic review was to re-assess the evidence for the dietary requirement of protein based on N-balance studies, and to assess the health effects of varying protein intake in healthy elderly populations based on prospective observational cohort or case–control studies and randomized controlled studies.
The process for conducting the systematic review is described in detail in the guidelines devised by the NNR5 working group ( Definition of the research questions to be answered. Definition of the eligibility criteria. A systematic search that attempts to identify all studies that would meet the eligibility criteria. A systematic selection and evaluation of the included papers. Construction of summary tables of the studies. Rating the evidence and formulate conclusions.
The main protein expert group for the adult population made the research questions in cooperation with other relevant expert groups including the
We included studies reporting protein intake from foods, but excluded studies using isolated protein as supplements, as well as studies based on the intake of certain amino acids.
Studies of general healthy elderly populations with a mean age of ≥ 65 years in settings similar to the Nordic countries were included, while studies with disabled/frail elderly were excluded. But since the review deals with elderly people, the described studies are likely to include people with various health problems such as sarcopenia, cardiovascular risk factors like hypertension and dyslipidemia, or some diseases that did not hinder free-living. Studies without Caucasians or with Caucasians as a minority group were excluded. Secondary prevention studies, studies that addressed adiposity or obesity, and studies on athletes were also excluded.
Observational studies: prospective cohort studies and case–control studies were included, while cross-sectional studies were excluded. Studies were also excluded if length of follow-up was obviously too short to reliably assess the stated outcome. No studies with less than 1-year follow-up were included.
For controlled intervention studies, the required length of study depended on outcome; for N-balance studies the length was set to at least 14 days in accordance with a recent meta-analysis (
Publication language had to be English or any of the Nordic languages.
Original articles, meta-analyses, and systematic reviews were included. Narrative reviews were examined to ensure that all relevant studies were included.
2000 onward.
The protein expert group that addressed the adult population defined the search terms relevant for both adults and the elderly in collaboration with a librarian, see Appendix 2. The databases used were PubMed and SweMed (the latter was used to identify Nordic papers not published in PubMed). The main search included the period January 2000 to January 2011. An additional search was run in Medline through the PubMed platform in January 2012 in order to update the search with the most recent papers published from January to December 2011.
Screening of all the papers was carried out by the two authors. The
The total search included 301 abstracts. The initial main search included 267 abstracts screened for eligibility (
Flow-chart of the systematic literature review process. Numbers in brackets are the additional searches in 2011.
A total of 23 papers were quality graded, including two additional papers identified through reference lists from the included papers and the narrative reviews (
The reasons for exclusion of the 131 full text papers are shown in Appendix 3.
The studies used for the grading of evidence for protein requirements based on N-balance studies are one meta-analysis including 19 N-balance studies (
Summary table N-balance studies
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
|
||||||
| N-balance | Meta-analysis (3) | 235 M & W in 19 separate studies | EAR: 0.65 g/kg BW |
B | PROBABLE no difference between young and old based on N-balance studies | |
| 0.8 g/kg BW | N-balance (and body composition) | 14 week controlled metabolic study (8) | 10 M & W (55–77 y) | Steady state at 2 weeks, but decreased N-excretion between week 2 and 14 | B | |
| Low protein: |
N-balance | 3 x 18 days controlled metabolic study (9) | 23 young and 19 old M & W | Estimated RDA: |
A | |
| Low protein: |
N-balance (and body composition) | 3 x 18 days controlled metabolic study (10) | 11 W (70–81 y) | Mean adequate protein allowance was estimated to be 0.90 g/kg BW at week 2 and 0.76 g/kg BW at week 3, decreased N-excretion between week 2 and week 3 | B | |
| Usual Protein: 1.5 g/kg FFM (11–12 E%) |
N-balance (and glomerular filtration rate) | Controlled cross-over study (11) | 10 young and nine old M & W | N-balance not different between young and old and between men and women | B | |
| Usual Protein: 1.5 g/kg FFM (11–12 E%) |
Glomerular filtration rate (GFR) (and N-balance) | Controlled cross-over study (11) | 10 young and nine old M & W | GFR was lower in older participants and they had a lesser adaption response to the High protein diet | B | NO CONCLUSION |
General remark for Summary tables:
POS: positive association/effect.
INVERSE: negative association/effect.
NS: statistically non-significant association/effect.
NA: non-available.
Rand et al.'s meta-analysis from 2003 (
In 2001, Campbell et al. (
In a controlled metabolic study by Morse et al. (
In 2008, Campbell et al. (
A short-term study was also included because of an HP intake in the test meal versus usual protein (UP) intake (
In summary, the evidence is assessed as
The evidence of potential adverse effects of a HP diet (ca. 24 E%) based on only one study is regarded as
The evaluation of the association between protein intake and muscle mass among healthy elderly persons is based on one randomized controlled trial (
Summary table muscle mass
| Association of protein/effect ( in RCT) | ||||||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Exposure/Intervention | Outcome variable | Study | No. of participants (age) |
Total | Animal | Vegetable | Rating |
Strength of evidence: |
|
|
||||||||
| Marginal protein diet: |
Muscle mass, muscle fiber CSA | RCT (12) | 12 W (66–79 y) | POS | NA | NA | B | SUGGESTIVE regarding the association between muscle mass and a total protein intake in the range of 13–20 E% |
| Quintiles of total, animal and vegetable protein intake in g/day and E% |
Lean muscle mass (LM) and appendicular LM | Prospective cohort study (13) | 2, 066 M & W (70–79 y) | POS (NS*) | POS | NS | B | |
| Tertiles of total protein intake in g/day and E%Highest T ≈20 E%Lowest T ≈18 E% | Lean muscle mass (LM) and appendicular LM, and BMC | Prospective cohort study (14) | 862 W (75±3 y) | POS | NA | NA | C | |
*Among the subgroup of weight-stable participants.
In a small study with 12 healthy elderly women, Castaneda et al. (
In the Health ABC study, Houston et al. (
As part of a prospective randomized controlled cohort trial of supplemental calcium to prevent fractures, Meng et al. (
The evidence is assessed as
The evaluation of the association between protein and bone health is based on two randomized controlled trials, eight prospective cohort studies, and one case–control study, see Appendix 4,
Summary table bone health
| Association of protein/effect ( in RCT) | ||||||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Exposure/Intervention | Outcome variable | Study | No. of participants (age) |
Total | Animal | vegetable | Rating |
Strength of evidence: |
|
|
||||||||
| LP diet: 16±3 E% protein |
BMC | RCT (15) | 32 M & W |
POS | NA | NA | C | SUGGESTIVE for total protein intake and BMD |
| Total protein intake in g/day and in E% expressed in tertiles |
BMD | Prospective cohort(16) | 1,077 W (75±3 y) | POS | NA | NA | B | |
| Total protein intake in g/day expressed in tertiles |
BMD | Prospective cohort(14) | 862 W (75±3 y) | POS | NA | NA | C | |
| Total, animal and vegetable protein intake |
BMD | Prospective cohort (17) | 572 M & W | NS | POS (W only) | INVERSE | B | |
| Habitual protein intake (total, animal and vegetable) expressed as E% in tertiles in combination with 500 mg Ca and 17.5 µg vitamin D or placebo Highest tertile |
Bone loss | RCT (18) | 342 M & W (≥ 65 y) | INVERSE (only in the supplemented group) | NS | NS | B | NO CONCLUSION |
| Total, animal and vegetable protein intake expressed as E% and in quartiles |
bone loss |
Prospective cohort (19) | 615 M &W (68–91 y) | INVERSE | INVERSE | NS | B | |
| Total, animal and vegetable protein intake |
annual bone loss during 4 y |
Prospective cohort (17) | 572 M & W | NS | NS | NS | B | |
| Total protein intake in E% expressed in Quartiles. |
bone loss | Prospective cohort (20) | 92 W (65–77 y) | NS | NA | NA | C | |
| Energy adjusted protein intake (E%) and the ratio of animal to vegetable protein (A/V ratio) in tertiles. | bone loss | Prospective cohort (21) | 742 W (> 65 y) | NA | POS* | NA | C | |
| Total protein intake expressed as energy adjusted g/day in quartiles. |
Fracture risk (proximal femur) | Prospective cohort (22) | 946 M & W (app 75 y) | INVERSE** | NA | NA | B | NO CONCLUSION |
| Energy adjusted protein intake expressed as E% and the ratio of animal to vegetable protein (A/V ratio) in tertiles. | Fracture risk (femoral neck) | Prospective cohort (21) | 1,035 W (> 65 y) | NA | POS |
NA | C | |
| Total, animal and vegetable protein intake expressed in E% quartiles. Total protein intake: |
Facture risk |
Case–control (23) | M & W |
|
|
|
B | |
| Total, animal and vegetable protein intake expressed as g/day and as energy adjusted tertiles | risk of falls | Prospective cohort (24) | 807 M & W (75±4.8 y) | NS | NS | NS | C | NO CONCLUSION |
*Expressed as A/V ratio.
**The upper three quartiles compared to lowest quartile.
One intervention study (
In a randomized controlled study, Dawson-Hughes et al. (
The association between total protein intake and the relation to BMD after 1-year follow-up was assessed among Australian elderly women (
As part of a prospective randomized controlled cohort trial of supplemental calcium to prevent fractures, Meng et al. (
The Rancho Bernardo study among men and women (
The evidence is assessed as
One intervention study (
In a randomized controlled trial with calcium and vitamin D supplementation versus placebo, Dawson-Hughes and Harris (
In the Framingham Osteoporosis Study, Hannan et al. (
In the Rancho Bernardo study among men and women (
In an osteoporosis intervention study (the STOP IT trial), 96 women of the placebo group were followed prospectively for 3 years (
The Study of Osteoporotic Fractures in postmenopausal women (
The evidence is assessed as
Two prospective cohort studies (
The Study of Osteoporotic Fractures in postmenopausal women (
In the Framingham Osteoporosis Study (
In a case–control study from 1997 to 2001 including men and women stratified by age groups 50–69 or 70–89 years (
The evidence is assessed as
Only one study was identified on the association between protein intake and risk of falls (
The evaluation of the association between protein and physical training is based on only two randomized controlled trials (
In a strictly controlled metabolic study by Campbell et al. (
The study by Haub et al. (
Due to few studies, the evidence is assessed as
For some outcomes, only one study was identified on the association to protein intake and thus, the evidence is assessed as
The Rotterdam prospective cohort study (
In the Women's Health Initiative Observational Study (WHI-OS), quality graded as B, Beasley at al studied the risk of incident frailty among 24,471 non-frail elderly women (
The British National Diet and Nutrition Survey of people aged 65 years and over (
The main findings of this systematic review on protein intake and the relation to health outcomes in healthy elderly populations comparable to the Nordic populations, are that the evidence is assessed
It should be noted that the grading of the evidence was only based on studies from 2000 up to and including 2011, and for some outcomes inclusion of earlier studies might have resulted in different grading. The most recent recommendations of protein intake from USA (
N-balance remains the method of choice for determining protein requirement in adults. Nevertheless, there are limitations in this method that need to be addressed, such as being related to the accuracy of the measurements, the short duration of the studies and the difficulty in interpretation of the results. Rand et al.'s meta-analysis (
The objective of the high quality graded N-balance study by Campbell et al. (
An earlier study by Campbell et al. (
From these studies, we assess the evidence as
WHO/FAO/UNU (
Long-term health and functional outcomes related to various protein intakes are likely of greater potential importance than N-balance studies that only give short-term indications on what intake is needed to prevent loss of protein mass, that is, mainly muscle mass, and bone mass. It has to be emphasized that the processes of dietary-based losses of muscle mass and strength, that is, sarcopenia, and bone, that is, osteoporosis, are extremely slow. This means that it may take many years before these losses are: (
Prevention of sarcopenia, that is, the age-related loss of muscle mass, strength and function is highly relevant. Advanced sarcopenia is a part of physical frailty and thus, associated with increased likelihood of falls and impairment in the ability to perform activities of daily living (
The studies included in this systematic review also point at a
Based on a small randomized controlled trial (
The EFSA Panel (
During aging there is an average loss of both muscle and bone mass in the population, however, with very wide variations between individuals.
The role of dietary protein on bone health has been controversial. On the one hand, urinary calcium loss is increased by HP intakes, while on the other hand protein increases calcium absorption or bioavailability, which questions the net effect of HP diets on calcium economy and the effect on bone health (
We assess the evidence as
The positive association between protein intake and BMD/BMC was based on one intervention study (
A prospective cohort study (
Overall, the animal protein intake showed both positive (
Only few studies address the issue of regular protein intake for optimal effect of physical exercise in healthy old adults. We included two American medium term RCTs (
In addition, there are studies that use supplementation of protein hydrolysates in order to increase the protein intake during periods of resistance training. Such studies fall outside the scope of this review of effects by regular food, but they still provide understanding of potential effects of combined training and increased protein intake, and are thus mentioned briefly. A recent meta-analysis by Cermak et al. from 2012 (
There are two short-term studies that also should be mentioned regarding timing. In the study by Andrews et al. (
Some outcomes, that is, hypertension, frailty, and mortality, were only addressed in one article, and thus, the evidence was assessed as
Potential risks, e.g. kidney damage or hypertension, of HP intakes need to be addressed. The N-balance study by Walrand et al. (
In a prospective cohort study (
Except from the strictly controlled metabolic studies it has generally been difficult to assess the actual protein intake in the observational studies due to misreporting (underreporting). The FFQ is a widespread dietary assessment method in observational studies. Based on a thorough calibration study, Beasley et al. (
Still, taken together studies on protein intake and long-term outcomes related to muscle mass (
The evidence is assessed as
There are still only few studies in this particular population and no new data justify a modification from the current estimated requirement.
The progressive loss of muscle mass and function (sarcopenia) as well as osteoporosis are true problems of the old population. It is likely to assume that these processes are too slow for short-term N-balance studies as well as short-term intervention studies to discover potentially beneficial effects from a slightly increased protein intake.
The estimation of an
Overall, many of the included prospective cohort studies were difficult to fully evaluate since results mainly were obtained by FFQs that were flawed by underreported intakes, despite some studies were ‘calibrated’ to correct for under- or over-reporting.
The overall impression from the included studies in the systematic review is that the optimal protein intake may be higher than the estimated RDA assessed from N-balance studies, whereas an exact level cannot be determined.
Regarding harmful effects of a HP intake, the evidence is considered as
Special thanks to the librarians Hege Sletsjøe and Jannes Engqvist, and to Ulla-Kaisa Koivisto Hursti and Wulf Becker for their help and guidance.
The authors have not received any funding or benefits from industry or elsewhere to conduct this study.
The effects or associations marked with * should be reviewed in cooperation with or in the relevant expert groups (e.g. infants and children, elderly, pregnant and lactating women). What is the What is the association and what are the effects of different intake, timing and frequency of protein and protein of different dietary sources, while considering intake of other energy giving nutrients at the same time, on:
Appendix 3. Excluded full text papers
|
|
|
|---|---|
|
|
|
| Andrews, R. D., D. A. MacLean, et al. (2006). “Protein intake for skeletal muscle hypertrophy with resistance training in seniors.” International Journal of Sport Nutrition and Exercise Metabolism 16(4): 362–372 | Intervention with soy protein isolate |
| Bell, J. and S. J. Whiting (2002). “Elderly women need dietary protein to maintain bone mass.” Nutrition Reviews 60(10:Pt:1): t–41 | Review |
| Berndt, S. I., H. B. Carter, et al. (2002). “Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging.” Urology 60(6): 1118–1123 | Main focus on calcium |
| Berrut, G., A. M. Favreau, et al. (2002). “Estimation of calorie and protein intake in aged patients: validation of a method based on meal portions consumed.” Journals of Gerontology Series A-Biological Sciences and Medical Sciences 57(1): M52–M56 | Patients |
| Biolo, G., B. Ciocchi, et al. (2007). “Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest.” American Journal of Clinical Nutrition 86(2): 366–372 | Not elderly |
| Bischoff Ferrari, H. A. (2009). “Validated treatments and therapeutic perspectives regarding nutritherapy.” Journal of Nutrition, Health and Aging 13(8): 737–741 | Review |
| Boirie, Y. (2009). “Physiopathological mechanism of sarcopenia.” Journal of Nutrition, Health and Aging 13(8): 717–723 | Review |
| Bonnefoy, M., C. Cornu, et al. (2003). “The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals: a long-term controlled randomized study.” British Journal of Nutrition 89(5): 731–739 | Frail elderly |
| Bonnefoy, M., T. Constans, et al. (2000). “Influence of nutrition and physical activity on muscle in the very elderly.” Presse Medicale 29(39): 2177–2182 | French language |
| Bossingham, M. J., N. S. Carnell, et al. (2005). “Water balance, hydration status, and fat-free mass hydration in younger and older adults.” American Journal of Clinical Nutrition 81(6): 1342–1350 | Not protein |
| Campbell, W. W. (2007). “Synergistic use of higher-protein diets or nutritional supplements with resistance training to counter sarcopenia.” Nutrition Reviews 65(9): 416–422 | Review |
| Campbell, W. W. and H. J. Leidy (2007). “Dietary protein and resistance training effects on muscle and body composition in older persons.” Journal of the American College of Nutrition 26(6): 696S–703S | Review |
| Campbell, W. W., M. D. Haub, et al. (2009). “Resistance training preserves fat-free mass without impacting changes in protein metabolism after weight loss in older women.” Obesity 17(7): 1332–1339 | Training after weight loss |
| Candow, D. G. and P. D. Chilibeck (2008). “Timing of creatine or protein supplementation and resistance training in the elderly.” Applied Physiology, Nutrition, and Metabolism=Physiologie Appliquee, Nutrition et Metabolisme 33(1): 184–190 | Review |
| Caso, G., J. Feiner, et al. (2007). “Response of albumin synthesis to oral nutrients in young and elderly subjects.” American Journal of Clinical Nutrition 85(2): 446–451 | Albumin synthesis, not protein |
| Chaput, J. P., C. Lord, et al. (2007). “Relationship between antioxidant intakes and class I sarcopenia in elderly men and women.” Journal of Nutrition, Health and Aging 11(4): 363–369 | Cross-sectional |
| Charlton, K. E. (2002). “Eating well: ageing gracefully!” Asia Pacific Journal of Clinical Nutrition 11: Suppl-17 | Review |
| Chernoff, R. (2004). “Protein and older adults.” Journal of the American College of Nutrition 23(6:Suppl): Suppl-630S | Review |
| Chevalier, S., E. D. Goulet |
Short-term |
| Chevalier, S., R. Gougeon, et al. (2003). “Frailty amplifies the effects of aging on protein metabolism: role of protein intake.” American Journal of Clinical Nutrition 78(3): 422–429 | Frailty |
| Chevalley, T., P. Hoffmeyer, et al. (2010). “Early serum IGF-I response to oral protein supplements in elderly women with a recent hip fracture.” Clinical Nutrition 29(1): 78–83 | Protein supplements, patients |
| Coin, A., E. Perissinotto, et al. (2008). “Predictors of low bone mineral density in the elderly: the role of dietary intake, nutritional status and sarcopenia.” European Journal of Clinical Nutrition 62(6): 802–809 | Cross-sectional |
| Darmon, P., M. J. Kaiser, et al. (2010). “Restrictive diets in the elderly: never say never again?” Clinical Nutrition 29(2): 170–174 | Review |
| Davies, K. M., R. P. Heaney, et al. (2002). “Decline in muscle mass with age in women: a longitudinal study using an indirect measure.” Metabolism: Clinical and Experimental 51(7): 935–939 | Not elderly |
| Davy, K. P., T. Horton, et al. (2001). “Regulation of macronutrient balance in healthy young and older men.” International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 25(10): 1497–1502 | Cross-sectional |
| Dillon, E. L., M. Sheffield-Moore, et al. (2009). “Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women.” Journal of Clinical Endocrinology and Metabolism 94(5): 1630–1637 | Amino acid supplementation |
| DiMaria-Ghalili, R. A. and E. Amella (2005). “Nutrition in older adults.” American Journal of Nursing 105(3): 40–50 | Review |
| Dorrens, J. and M. J. Rennie (2003). “Effects of ageing and human whole body and muscle protein turnover.” Scandinavian Journal of Medicine and Science in Sports 13(1): 26–33 | Review |
| Dreyer, H. C. and E. Volpi (2005). “Role of protein and amino acids in the pathophysiology and treatment of sarcopenia.” Journal of the American College of Nutrition 24(2): 140S–145S | Review |
| Durham, W. J., S. L. Casperson, et al. (2010). “Age-related anabolic resistance after endurance-type exercise in healthy humans.” FASEB Journal 24(10): 4117–4127 | Amino acid infusion |
| Esmarck, B., J. L. Andersen, et al. (2001). “Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans.” Journal of Physiology 535(Pt:1): 1–11 | Supplementation with a gel of hydrolyzed protein |
| Evans, W. J. (2002). “Effects of exercise on senescent muscle.” Clinical Orthopaedics and Related Research(403:Suppl): Suppl-20 | Review |
| Evans, W. J. (2004). “Protein nutrition, exercise and aging.” Journal of the American College of Nutrition 23(6:Suppl): Suppl-609S | Review |
| Ferrando, A. A., D. Paddon-Jones, et al. (2010). “EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly.” Clinical Nutrition 29(1): 18–23 | EAA supplementation |
| Freeman, S. L., L. Fisher, et al. (2010). “Dairy proteins and the response to pneumovax in senior citizens: a randomized, double-blind, placebo-controlled pilot study.” Annals of the New York Academy of Sciences 1190: 97–103 | Protein powder supplement |
| Fujita, S. and E. Volpi (2006). “Amino acids and muscle loss with aging.” Journal of Nutrition 136(1:Suppl): Suppl-80S | Review |
| Fukagawa, N. K. and R. A. Galbraith (2004). “Advancing age and other factors influencing the balance between amino acid requirements and toxicity.” Journal of Nutrition 134(6:Suppl): Suppl-1574S | Review |
| Gaffney-Stomberg, E., K. L. Insogna, et al. (2009). “Increasing dietary protein requirements in elderly people for optimal muscle and bone health.” Journal of the American Geriatrics Society 57(6): 1073–1079 | Review |
| Gaillard, C., E. Alix, et al. (2008). “Are elderly hospitalized patients getting enough protein?” Journal of the American Geriatrics Society 56(6): 1045–1049 | Patients |
| Genaro Pde, S. and L. A. Martini (2010). “Effect of protein intake on bone and muscle mass in the elderly. [Review].” Nutrition Reviews 68(10): 616–623 | Review |
| Giovannucci, E., M. Pollak, et al. (2003). “Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.” Cancer Epidemiology, Biomarkers and Prevention 12(2): 84–89 | Cross-sectional |
| Gordon, M. M., M. J. Bopp, et al. (2008). “Effects of dietary protein on the composition of weight loss in post-menopausal women.” Journal of Nutrition, Health and Aging 12(8): 505–509 | During weight loss in obesity |
| Goulet, E. D., C. Lord, et al. (2007). “No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study.” Applied Physiology, Nutrition, and Metabolism=Physiologie Appliquee, Nutrition et Metabolisme 32(3): 426–433 | Not protein |
| Greenwood, C. E. (2003). “Dietary carbohydrate, glucose regulation, and cognitive performance in elderly persons.” Nutrition Reviews 61(5:Pt:2): t-74 | Review |
| Guillet, C. and Y. Boirie (2005). “Insulin resistance: a contributing factor to age-related muscle mass loss?” Diabetes and Metabolism 31: Spec-5S26 | Review |
| Haub, M. D., A. M. Wells, et al. (2005). “Beef and soy-based food supplements differentially affect serum lipoprotein–lipid profiles because of changes in carbohydrate intake and novel nutrient intake ratios in older men who resistive-train.” Metabolism: Clinical and Experimental 54(6): 769–774 | Not protein |
| Hays, N. P., H. Kim, et al. (2009). “Effects of whey and fortified collagen hydrolysate protein supplements on nitrogen balance and body composition in older women.” Journal of the American Dietetic Association 109(6): 1082–1087 | Protein supplement (hydrolysates) |
| Iglay, H. B., J. P. Thyfault, et al. (2007). “Resistance training and dietary protein: effects on glucose tolerance and contents of skeletal muscle insulin signaling proteins in older persons.” American Journal of Clinical Nutrition 85(4): 1005–1013 | Not elderly (61 ±1 yr) |
| Iglay, H. B., J. W. Apolzan, et al. (2009). “Moderately increased protein intake predominately from egg sources does not influence whole body, regional, or muscle composition responses to resistance training in older people.” Journal of Nutrition, Health and Aging 13(2): 108–114 | Not elderly (61 ±1 yr) |
| Ilich, J. Z., R. A. Brownbill, et al. (2003). “Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density.” European Journal of Clinical Nutrition 57(4): 554–565 | Cross-sectional |
| Jensen, G. L. (2008). “Inflammation: roles in aging and sarcopenia.” Jpen: Journal of Parenteral and Enteral Nutrition 32(6): 656–659 | Review |
| Johnson, M. A., J. T. Dwyer |
Review |
| Jordan, L. Y., E. L. Melanson, et al. (2010). “Nitrogen balance in older individuals in energy balance depends on timing of protein intake.” Journals of Gerontology Series A-Biological Sciences and Medical Sciences 65(10): 1068–1076 | Short-term |
| Kaluza, J., J. Dolowa, et al. (2005). “Survival and habitual nutrient intake among elderly men.” Roczniki Panstwowego Zakladu Higieny 56(4): 361–370 | Polish language |
| Kaplan, R. J., C. E. Greenwood, et al. (2001). “Dietary protein, carbohydrate, and fat enhance memory performance in the healthy elderly.” American Journal of Clinical Nutrition 74(5): 687–693 | Short-term |
| Kenny, A. M., K. M. Mangano, et al. (2009). “Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial.” American Journal of Clinical Nutrition 90(1): 234–242 | Protein isolates |
| Kim, J. S., J. M. Wilson, et al. (2010). “Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants.” Journal of Nutritional Biochemistry 21(1): 1–13 | Review |
| Koopman, R. (2011). “Dietary protein and exercise training in ageing.” Proceedings of the Nutrition Society 70(1): 104–113 | Review |
| Kukuljan, S., C. A. Nowson, et al. (2009). “Effects of resistance exercise and fortified milk on skeletal muscle mass, muscle size, and functional performance in middle-aged and older men: an 18-mo randomized controlled trial.” Journal of Applied Physiology 107(6): 1864–1873 | Not protein (fortification) |
| Kurpad, A. V. and M. Vaz (2000). “Protein and amino acid requirements in the elderly.” European Journal of Clinical Nutrition 54: Suppl-42 | Review |
| Larsson, S. C., K. Wolk, et al. (2005). “Association of diet with serum insulin-like growth factor I in middle-aged and elderly men.” American Journal of Clinical Nutrition 81(5): 1163–1167 | Cross-sectional |
| Lim, L. S., L. J. Harnack, et al. (2004). “Vitamin A intake and the risk of hip fracture in postmenopausal women: the Iowa Women's Health Study.” Osteoporosis International 15(7): 552–559 | Not protein |
| Lin, Y. C., J. F. Chiu, et al. (2005). “Bone health status of the elderly in Taiwan by quantitative ultrasound.” Asia Pacific Journal of Clinical Nutrition 14(3): 270–277 | Asian population |
| Longcope, C., H. A. Feldman, et al. (2000). “Diet and sex hormone-binding globulin.” Journal of Clinical Endocrinology and Metabolism 85(1): 293–296 | Cross-sectional |
| Lord, C., J. P. Chaput, et al. (2007). “Dietary animal protein intake: association with muscle mass index in older women.” Journal of Nutrition, Health and Aging 11(5): 383–387 | Cross-sectional |
| Lucas, M. and C. J. Heiss (2005). “Protein needs of older adults engaged in resistance training: a review.” Journal of Aging and Physical Activity 13(2): 223–236 | Review |
| Martin, H., A. Aihie Sayer |
Cross-sectional |
| Mathus-Vliegen, E. M. (2004). “Old age, malnutrition, and pressure sores: an ill-fated alliance.” Journals of Gerontology Series A-Biological Sciences and Medical Sciences 59(4): 355–360 | Patients |
| Mattson, M. P., W. Duan, et al. (2001). “Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms.” Mechanisms of Ageing and Development 122(7): 757–778 | Dietary restriction |
| McFarlin, B. K., M. G. Flynn, et al. (2006). “Energy restriction with different protein quantities and source: implications for innate immunity.” Obesity 14(7): 1211–1218 | Energy restriction |
| Mercier, S., D. Breuille, et al. (2006). “Methionine kinetics are altered in the elderly both in the basal state and after vaccination.” American Journal of Clinical Nutrition 83(2): 291–298 | Amino acid metabolism (methionine) |
| Miller, G. D. (2010). “Improved nutrient intake in older obese adults undergoing a structured diet and exercise intentional weight loss program.” Journal of Nutrition, Health and Aging 14(6): 461–466 | Weight loss program in obesity |
| Millward, D. J. (2008). “Sufficient protein for our elders?” American Journal of Clinical Nutrition 88(5): 1187–1188 | Review |
| Morais, J. A., S. Chevalier, et al. (2006). “Protein turnover and requirements in the healthy and frail elderly.” Journal of Nutrition, Health and Aging 10(4): 272–283 | Review |
| Moriguti, J. C., E. Ferriolli, et al. (2005). “Effects of arginine supplementation on the humoral and innate immune response of older people.” European Journal of Clinical Nutrition 59(12): 1362–1366 | Amino acid supplementation |
| Murad, H. and M. P. Tabibian (2001). “The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study.” Journal of Dermatological Treatment 12(1): 47–51 | Supplements |
| Nakamura, K., Y. Hori, et al. (2003). “Nutritional covariates of dietary calcium in elderly Japanese women: results of a study using the duplicate portion sampling method.” Nutrition 19(11–12): 922–925 | Japanese |
| Nakamura, K., Y. Hori, et al. (2004). “Dietary calcium, sodium, phosphorus, and protein and bone metabolism in elderly Japanese women: a pilot study using the duplicate portion sampling method.” Nutrition 20(4): 340–345 | Japanese |
| Nieves, J. W. (2003). “Calcium, vitamin D, and nutrition in elderly adults.” Clinics in Geriatric Medicine 19(2): 321–335 | Review |
| Onambele-Pearson, G. L., L. Breen, et al. (2010). “Influences of carbohydrate plus amino acid supplementation on differing exercise intensity adaptations in older persons: skeletal muscle and endocrine responses.” Age 32(2): 125–138 | Amino acid supplementation |
| Oomen, C. M., M. J. van Erk, et al. (2000). “Arginine intake and risk of coronary heart disease mortality in elderly men.” Arteriosclerosis, Thrombosis and Vascular Biology 20(9): 2134–2139 | Amino acid intake |
| Paddon-Jones, D. and B. B. Rasmussen (2009). “Dietary protein recommendations and the prevention of sarcopenia.” Current Opinion in Clinical Nutrition and Metabolic Care 12(1): 86–90 | Review |
| Paddon-Jones, D., K. R. Short, et al. (2008). “Role of dietary protein in the sarcopenia of aging.” American Journal of Clinical Nutrition 87(5): 1562S–1566S | Review |
| Pfrimer, K., J. S. Marchini, et al. (2009). “Fed state protein turnover in healthy older persons under a usual protein-rich diet.” Journal of Food Science 74(4): H112–H115 | Short-term |
| Pitkanen, H. T., S. S. Oja, et al. (2003). “Serum amino acid concentrations in aging men and women.” Amino Acids 24(4): 413–421 | Cross-sectional |
| Pounis, G. D., S. Tyrovolas |
Cross-sectional |
| Rennie, M. J. (2009). “Anabolic resistance: the effects of aging, sexual dimorphism, and immobilization on human muscle protein turnover.” Applied Physiology, Nutrition, and Metabolism=Physiologie Appliquee, Nutrition et Metabolisme 34(3): 377–381 | Review |
| Rieu, I., M. Balage, et al. (2006). “Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia.” Journal of Physiology 575(Pt:1): 1–15 | Amino acid supplementation |
| Risonar, M. G., P. Rayco-Solon, et al. (2009). “Physical activity, energy requirements, and adequacy of dietary intakes of older persons in a rural Filipino community.” Nutrition Journal 8: 19 | Filipino study |
| Ritz, P. (2000). “Physiology of aging with respect to gastrointestinal, circulatory and immune system changes and their significance for energy and protein metabolism.” European Journal of Clinical Nutrition 54: Suppl-5 | Review |
| Ritz, P. (2001). “Factors affecting energy and macronutrient requirements in elderly people.” Public Health Nutrition 4(2B): 561–568 | Review |
| Rodondi, A., P. Ammann, et al. (2009). “Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly.” Journal of Nutrition, Health and Aging 13(6): 491–497 | Zinc and frail elderly |
| Rolland, Y. and F. Pillard (2009). “Validated treatments and therapeutic perspectives regarding physical activities.” Journal of Nutrition, Health and Aging 13(8): 742–745 | Review |
| Rolland, Y., C. Dupuy |
Review |
| Roubenoff, R. (2000). “Sarcopenia: a major modifiable cause of frailty in the elderly.” Journal of Nutrition, Health and Aging 4(3): 140–142 | Review |
| Sahyoun, N. R., A. L. Anderson, et al. (2008). “Dietary glycemic index and glycemic load and the risk of type 2 diabetes in older adults.” American Journal of Clinical Nutrition 87(1): 126–131 | Not focus on protein |
| Sallinen, J., A. Pakarinen, et al. (2006). “Serum basal hormone concentrations and muscle mass in aging women: effects of strength training and diet.” International Journal of Sport Nutrition and Exercise Metabolism 16(3): 316–331 | Not elderly (58±6 y) |
| Sallinen, J., A. Pakarinen, et al. (2007). “Dietary intake, serum hormones, muscle mass and strength during strength training in 49–73-year-old men.” International Journal of Sports Medicine 28(12): 1070–1076 | Not elderly (59 ±6 y) |
| Scognamiglio, R., A. Avogaro, et al. (2004). “The effects of oral amino acid intake on ambulatory capacity in elderly subjects.” Aging-Clinical and Experimental Research 16(6): 443–447 | Amino acid supplementation |
| Scognamiglio, R., R. Piccolotto, et al. (2005). “Oral amino acids in elderly subjects: effect on myocardial function and walking capacity.” Gerontology 51(5): 302–308 | Amino acid supplementation |
| Scott, D., L. Blizzard, et al. (2010). “Associations between dietary nutrient intake and muscle mass and strength in community-dwelling older adults: the Tasmanian Older Adult Cohort Study.” Journal of the American Geriatrics Society 58(11): 2129–2134 | Not elderly |
| Selhub, J., L. C. Bagley, et al. (2000). “B vitamins, homocysteine, and neurocognitive function in the elderly.” American Journal of Clinical Nutrition 71(2): 614S–620S | Not protein |
| Sjogren, P., W. Becker, et al. (2010). “Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden.” American Journal of Clinical Nutrition 92(4): 967–974 | Not protein (dietary patterns) |
| Solerte, S. B., C. Gazzaruso, et al. (2008). “Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia.” American Journal of Cardiology 101(11A): 69E–77E | Amino acid supplementation |
| Song, Y., J. E. Manson, et al. (2004). “A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study.” Diabetes Care 27(9): 2108–2115 | Not protein (food based) |
| Stookey, J. D., L. S. Adair, et al. (2005). “Do protein and energy intakes explain long-term changes in body composition?” Journal of Nutrition, Health and Aging 9(1): 5–17 | Chinese |
| Strassburg, A., C. Krems, et al. (2004). “Effect of age on plasma homocysteine concentrations in young and elderly subjects considering serum vitamin concentrations and different lifestyle factors.” International Journal for Vitamin and Nutrition Research 74(2): 129–136 | Not protein |
| Symons, T. B., M. Sheffield-Moore, et al. (2009). “A moderate serving of high-quality protein maximally stimulates skeletal muscle protein synthesis in young and elderly subjects.” Journal of the American Dietetic Association 109(9): 1582–1586 | Short-term |
| Symons, T. B., S. E. Schutzler, et al. (2007). “Aging does not impair the anabolic response to a protein-rich meal.” American Journal of Clinical Nutrition 86(2): 451–456 | Short-term |
| Thalacker-Mercer, A. E. and W. W. Campbell (2008). “Dietary protein intake affects albumin fractional synthesis rate in younger and older adults equally.” Nutrition Reviews 66(2): 91–95 | Review |
| Thalacker-Mercer, A. E., J. C. Fleet, et al. (2007). “Inadequate protein intake affects skeletal muscle transcript profiles in older humans.” American Journal of Clinical Nutrition 85(5): 1344–1352 | Short-term |
| Timmerman, K. L. and E. Volpi (2008). “Amino acid metabolism and regulatory effects in aging.” Current Opinion in Clinical Nutrition and Metabolic Care 11(1): 45–49 | Review |
| Tucker, K. L., et al. (2001). “The acid–base hypothesis: diet and bone in the Framingham Osteoporosis Study.” European Journal of Nutrition 40(5): 231–237. | Same data as Hannan et al. 2000 |
| Tyrovolas, S., T. Psaltopoulou |
Cross-sectional |
| Verdijk, L.B., et al. (2009) ”Protein supplementation before and after exercise does not further augment skeletal muscle hypertrophy after resistance training in elderly men.” American Journal of Clinical Nutrition 89(2):608–16. | Casein hydrolysate |
| Verhoeven, S., K. Vanschoonbeek, et al. (2009). “Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men.” American Journal of Clinical Nutrition 89(5): 1468–1475 | Amino acid supplementation |
| Visser, M., S. B. Kritchevsky, et al. (2005). “Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study.” American Journal of Clinical Nutrition 82(3): 531–537 | Se-albumin, not protein |
| Visvanathan, R. and I. Chapman (2010). “Preventing sarcopaenia in older people.” Maturitas 66(4): 383–388 | Review |
| Volkert, D., K. Kreuel, et al. (2004). “Energy and nutrient intake of young–old, old–old and very-old elderly in Germany.” European Journal of Clinical Nutrition 58(8): 1190–1200 | Cross-sectional |
| Volpi, E., H. Kobayashi, et al. (2003). “Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults.” American Journal of Clinical Nutrition 78(2): 250–258 | Amino acid supplementation |
| Wagner, E. A., G. A. Falciglia, et al. (2007). “Short-term exposure to a high-protein diet differentially affects glomerular filtration rate but not Acid–base balance in older compared to younger adults.” Journal of the American Dietetic Association 107(8): 1404–1408 | Short-term |
| Walrand, S. (2010). “Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia?” Journal of Nutrition, Health & Aging 14(7): 570–577 | Review |
| Walrand, S. and Y. Boirie (2005). “Optimizing protein intake in aging.” Current Opinion in Clinical Nutrition and Metabolic Care 8(1): 89–94 | Review |
| Walrand, S., C. Guillet |
Review |
| Waters, D. L., R. N. Baumgartner, et al. (2000). “Sarcopenia: current perspectives.” Journal of Nutrition, Health and Aging 4(3): 133–139 | Review |
| Waters, D. L., R. N. Baumgartner, et al. (2010). “Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update.” Clinical Interventions In Aging 5: 259–270 | Review |
| Wells, A. M., M. D. Haub, et al. (2003). “Comparisons of vegetarian and beef-containing diets on hematological indexes and iron stores during a period of resistive training in older men.” Journal of the American Dietetic Association 103(5): 594–601 | Vegetarian versus beef diet, not protein |
| Wernette, C. M., B. D. White |
Review |
| Wilson, M. M., R. Purushothaman, et al. (2002). “Effect of liquid dietary supplements on energy intake in the elderly.” American Journal of Clinical Nutrition 75(5): 944–947 | Short-term |
| Wolfe, R. R., S. L. Miller, et al. (2008). “Optimal protein intake in the elderly.” Clinical Nutrition 27(5): 675–684 | Review |
| Zhu, K., X. Meng |
Protein isolate |
| Reference | Study design | Population | Outcome measures | Intervention/exposure | Dietary assessment method | No of subjects analysed | Intervention | Results | Study quality and relevance, Comments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
| Campbell et al., 2001 (8) |
Controlled metabolic study | 10 healthy men and postmenopausal women aged 55–77 y | N-balance and body composition (whole body density, body water, mid-thigh muscle area) | Diet was a rotating cycle of three daily menus of lacto-ovo-vegetarian foods (animal protein from egg and dairy) | 14 week strictly controlled dietary intake trial. Weeks 2, 8 and 14 at the clinic for testing and evaluating: four consecutive 24-h urine and four-day fecal collections. No assessment of miscellaneous losses |
Four men and six women | Eucaloric diets containing 0.8 g protein/kg body weight (BW) /day | Steady state reached at week 2. |
|
| Campbell et al., 2008 (9) |
Controlled metabolic study | Healthy volunteers, young (n=27) 29–30 ±7–8 y and old (n=21) 72–75 ±6–4 y, |
N-balance | Low protein diet: |
Strict dietary control. All weekday morning meals were consumed at the research center, lunch, dinner and weekend meals were packaged and taken home. Duplicate portions of all foods and beverages on days 7–10 of each trial. Stool collections on day 7–9 of each trial. |
Young n=23 |
Three 18-d periods, minimum one week habitual diet between the periods. |
BW unchanged. N-balance not different between the four groups. Estimated requirement expressed pr. kg BW was not significantly different for the young vs. old or men vs. women. Mean protein requirement was lower for older women vs. older men, but expressed pr. kg FFM there was no significant difference. |
|
| Morse et al., 2001 (10) |
Controlled metabolic study | 12 healthy women aged 70–81 y | N-balance, body composition, resting metabolic rate | Low protein diet: |
Strict dietary control. Duplicate portions of all foods and beverages, stool collections and 24-h urine collections on day 7–10 and 14–17 of each trial. |
11 women | Three 18-d periods, minimum one week habitual diet between the periods. |
Unchanged BW and body composition, |
|
| Rand et al., 2003 (3) | Meta-analysis | 19 balance studies among healthy persons | N-balance | Controlled nitrogen (protein) intake. |
N=235 | The median estimated protein requirement of good quality protein: 0.66 g/kg BW/d and the estimated RDA: 0.83 g/kg BW/d |
|
||
| Walrand et al., 2009 (11) USA | Controlled study |
10 healthy young 24 ±1 y (5 men) |
N-balance, glomerular filtration rate (GFR), |
High protein (HP): 3.0 g/kg FFM and usual protein (UP): 1.5 g/kg fat free mass (FFM) | All food was prepared at the metabolic ward. |
10 young and nine old | 10 days of HP (Young: 2.08±0.07 g/kg BW and old: 1.79±0.1 g/kg BW) or |
Unchanged body weight. N-balance and muscle protein synthesis did not differ with age. GFR was lower in older participants and they had a lesser increase in GFR during the HP diet corresponding to 77% of younger people at the UP and 58% of younger people during HP |
|
functional or clinical outcomes including pregnancy* or birth outcomes*, growth, development and sarcopenia* cardiovascular diseases, weight outcomes, cancer, type 2-diabetes, fractures, renal outcomes, physical training, muscular strength and mortality
| Reference | Study design | Population | Outcome measures | Intervention/exposure | Time between baseline exposure and outcome assessment | Dietary assessment method | No of subjects analysed | Intervention | Follow-up period, drop-out rate | Results | Confounders adjusted for | Study quality and relevance, Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
| Castaneda et al., 2000 (12) |
RCT | 12 healthy women, 66–79 y, sedentary to moderately active | Muscle fiber cross-sectional area (CSA), |
Marginal protein diet: |
10 weeks | All food was provided | 12 | 3-day baseline milk-based meat-free diet containing 1.2 g protein/kg BW and then randomized to a weight-maintaining (eucaloric) diet with marginal or adequate protein. |
Marginal protein intake resulted in a decrease in muscle mass from 17 ±0.9 kg to 14.7 ±0.8 kg and decreased muscle mass fiber CSA (type I fibers) and IGF-I, while the adequate intake resulted in increased fiber CSA (type I fibers) and IGF-I | Energy intake |
|
|
| Houston et al., 2008 |
Prospective cohort | 2,732 community-dwelling white and black, 70–79 y in the Health, Aging, and Body Composition (Health ABC) Study. | Body comp (DXA), |
1. Protein intake (E% and g/day) in quintiles. |
FFQ 108 items, developed specifically for the study, but no information about validation. |
2,066, 74 y, 53% Caucasians | Mean protein intake 0.9 g/kg BW/d, mean loss of LM 0.68±1.9 kg | 3 year | Highest Q5 ( ≈19 E%) of protein intake lost 40% less LM and aLM compared to the lowest Q ( ≈11 E%). Vegetable protein did not relate to loss of LM. |
age, sex, race, study site, energy intake, LM or aLM, height, smoking, alcohol, physical activity, prevalent disease (DM, CVD, cancer, COPD, steroids, interim hospitalizations | B | |
| Meng et al., 2009 |
Prospective cohort | 1,169 out of 1,500 community-dwelling women (70–85 y) did 5 years follow-up and of these 906 had a whole body DXA | Lean mass, aLM, | Tertiles of protein intake in g/day | FFQ |
862, 75±3 y | Mean protein intake 1.2 g/kg BW/d or 19 E% |
5 year | Top tertile protein intake had ∼5% higher LM/aLM compared to the lowest | Age, height, energy intake, physical activity |
|
|
| Reference | Study design | Population | Outcome measures | Intervention/exposure | Time between baseline exposure and outcome assessment | Dietary assessment method | No of subjects analysed | Intervention | Follow-up period, drop-out rate | Results | Confounders adjusted for | Study quality and relevance, Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
| Dawson-Hughes and Harris, 2002 (18) |
RCT | 389 men and women aged ≥ 65 y | Bone loss (BMD every 6 months at femoral neck, spine and total body) | 500 mg Calcium and 17.5 µg vitamin D or placebo and in combination with habitual protein intake (total, animal and vegetable) assessed at 18 month visit and expressed as E% in tertiles | 126-item FFQ (Willet, version 1988) administered on site and reviewed for completeness by staff. |
342 | Mean total protein intake 79.1±25.6 g/day. Mean calcium intake in placebo group: 871±413 mg, and 1346±358 in the supplemented group. |
3 y | In the intervention group (with calcium and vitamin D) the highest tertile was associated with less total body BMD loss (P=0.046) and at femoral neck (p= 0.001) compared to lowest tertile | Sex, age, BW, energy intake, dietary calcium intake, (physical activity, smoking) |
|
|
| Dawson-Hughes et al., 2004 |
RCT | 33 men and women aged ≥50 y. |
Urinary calcium excretion, Bone mineral content (BMC) |
Eucaloric diets |
FFQ self-administered on site and reviewed for completeness by a dietician. |
16 LP (71.8±9.8 y) |
LP diet: 16±3 E% protein. |
63 days | Weight stability. No difference in urinary calcium excretion. The HP group had increased BMC over 9 weeks (p=0.049) but not in LP group |
|
||
| Devine et al., 2005 |
Prospective cohort | Originally a 5-y trial of calcium supplementation and fracture outcome. 18% response rate and 1/3 were included in the present study. |
BMD at the hip after 1 year | Total protein intake in g/day and in E% expressed in tertiles | FFQ |
1,077 women | Mean total protein intake 1.2 g/kg BW or 19 E%. |
1 y | Protein intake associated to BMD: r=0.138 (p< 0.001) |
Age, BMI, calcium treatment |
|
|
| Hannan et al., 2000 (19) |
Prospective cohort | Framingham Osteoporosis Study |
BMD in femur, radial shaft and spine |
Total, animal and vegetable protein intake expressed as E% and in quartiles | 126-item FFQ (Willett) over the past year. |
615 (64% women) | Mean total protein intake 16 E% (7–30 E%) |
4 y |
Total and animal protein E% inversely related to bone loss at femur and spine. |
Age, sex, weight, height, weight change, energy intake, smoking, alcohol, caffeine, physical activity, calcium intake incl. supplement and hormone use |
|
|
| Meng et al., 2009 |
Prospective cohort | 1,169 out of 1,500 community-dwelling women (70–85 y) did 5 years follow-up and of these 906 had a whole body DXA | BMC | Tertiles of protein intake in g/day | FFQ |
862 women, 75±3 y | Mean protein intake 1.2 g/kg BW/d or 19 E% |
5 year | Top tertile protein intake vs. lowest tertile had a ∼5% higher whole body BMC | Age, height, energy intake, physical activity, calcium treatment |
|
|
| Misra et al., 2011 |
Prospective cohort | Framingham Osteoporosis Study |
Self-reported fracture of proximal femur confirmed by medical records. Incidence rates per 1000 persons-years | Total protein intake expressed as energy adjusted g/day and in quartiles | 126-item FFQ over the past year. |
946 (61% women) and 100 fractures | Mean intake app 68 g/day (ca 1.1 g/kg BW) |
11.6 person years | The upper three quartiles compared to lowest quartile: |
Age, sex, height, BW, energy intake | B | |
| Promislow et al., 2002 (17) |
Prospective cohort | The Rancho Bernardo Study |
Total BMD and at hip, femur, and spine at baseline |
Total, animal and vegetable protein intake |
128-item FFQ (Harvard-Willet). |
572 (65%) females and 388 (60%) males | Mean intake ca. 72 g/day |
4 year | For women, animal protein intake was positively associated and vegetable protein intake inversely associated with 4-y total BMD at hip femoral neck For men, vegetable protein intake was inversely associated to total body BMD and at hip and spine. |
Age, BMI, change in body weight, calcium intake incl. suppl., diabetes status, years of postmenopause, physical activity, smoking, alcohol, hormones intake | B | |
| Rapuri et al. 2003 (20) |
Prospective cohort |
489 women aged 65–77 y enrolled in an osteoporosis intervention study (the STOP IT trial). |
BMD at baseline (cross-sectional data) and bone loss after 3 y | Quartiles of protein intake in E% | 7-d food diaries. No information about validation | 92 women | Lowest quartile of total protein intake ≈13 E% |
3 y | NS association to 3-y-bone loss | Age, BMI, intakes of calcium, caffeine, fiber and vitamin D, smoking status and alcohol use |
|
|
| Sellmeyer et al., 2001 (21) |
Prospective cohort | 1,061 postmenopausal white women. Aged >65 y The Study of Osteoporotic Fractures. Multi-center | BMD and bone loss, self-reported hip fractures confirmed by radiologist reports | Energy adjusted total, animal and vegetable protein intake (E%) and the ratio of animal to vegetable protein (A/V ratio) in tertiles | BMD at baseline and after 3.6 years. |
63-item FFQ from the second NHANES study. Food models to estimate portion sizes. |
1,035 |
Median protein intake was 17E% |
Bone loss after 3.6 y. |
Bone loss positively related to A/V ratio. |
Age, weight, estrogen use, tobacco use, exercise, energy intake, total calcium intake, total protein E% |
|
| Wengreen et al., 2004 (23) |
Case–control study. |
Utah Study of Nutrition and Bone Health (USNBH) of Utah residents 50–89 yrs. |
Risk of hip fracture | Quartiles of total, animal and vegetable protein E% | 137-item FFQ |
Cases |
Mean total protein intake app 16 E%. |
Stratified by age group: |
Sex, BMI, smoking, alcohol, physical activity, estrogen use, intake of total calcium, vitamin D and potassium | B | ||
| Zoltick et al., 2011 |
Prospective cohort | Framingham Original Cohort study, n=1,402 at baseline in 1988–1989. (Originally 5,209 free-living men and women), residents in nursing homes excluded | Self-reported falls during last year, at baseline and at 12 months follow-up | Total, animal and vegetable protein expressed as g/day and as energy adjusted tertiles | Baseline and after 12 months | 126-item FFQ (Willett) |
807, 63% women, mean age 75±4.8 y | Mean total protein intake 69 g/day (ca. 16 E%) |
12 months | No statistically significant associations after 12 months follow-up | Age, sex, height, BW, energy intake, baseline falls, animal and plant protein intake adjusted for each other when examined |
|
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid
MEDLINE(R) <1950 to Present>
Search Strategy:
Appendix 4. Evidence tables Table 4. Evidence table: protein and physical training
| Reference | Study design | Population | Outcome measures | Intervention/exposure | Time between baseline exposure and outcome assessment | Dietary assessment method | No. of subjects analysed | Intervention | Follow-up period, drop-out rate | Results | Confounders adjusted for | Study quality and relevance, Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
| Campbell et al., 2002 (25) |
RCT | 29 healthy men (12) and women (17), 55–78 y | Body composition (deuterium dilution), muscle area: mid-thigh and mid-arm (CT), Strength, N-balance | Resistive training (RT) of lower body vs. whole body vs. sedentary. All received 0.8 g protein/kg BW/d in euenergetic (weight-maintaining) menus | 14 week | Participants were provided food | Body water and fat-free mass decreased and relative fat mass increased in general. Mid-thigh muscle area increased with RT, and decreased with sedentarism. It is concluded that with RT the body adapts to 0.8 g, whereas muscle mass was lost in the sedentary |
|
||||
| Haub et al., 2002(26) |
RCT | 26 healthy men | Body composition, muscle cross-sectional area, muscle strength | Euenergetic diets supplemented with 0.6 g/kg BW beef vs. 0.6 g/kg BW soy protein in combination with resistance training | 12 week | Food records for 3 days, week1 (habitual), w2 start of intervention, week 15 end of study | 21, 65±5 y, BMI 28 | Mean protein intake 1–1.17 g/kg BW. |
3 withdrew 1had a viral infection, 1 was iron deficient | Similar increases in lean mass, muscle cross-sectional area, and muscle strength |
|
|
| Reference | Study design | Population | Outcome measures | Intervention/exposure | Dietary assessment method | No of subjects analysed | Intervention | Follow-up period, drop-out rate | Results | Confounders adjusted for | Study quality and relevance, Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||
| Altorf-van der Kuil et al., 2010 (27) |
Prospective cohort | The Rotterdam study, 7,983 (78%) men and women at baseline,>55 y Participants with baseline hypertension (55%) excluded | Hypertension (SBP≥ 140 mmHg and DBP≥ 90 mm Hg) or use of antihypertensive medication | Energy adjusted total, animal and vegetable protein intake in g/day | A checklist about foods consumed at least twice a month during the preceding year followed by a 170-item interviewer administrated FFQ. Calibrated against fifteen 24-h food records and four 24-h urinary urea excretions. Correlations for total protein intake 0.66 and 0.59 for vegetable protein intake | 2,241 (65±7 yr), 43% men. |
Energy adjusted tertiles of total protein in g/day intake were: |
6 y | Non-significant associations between hypertension and total, animal and vegetable protein. |
Age, sex, BMI, baseline SBP, smoking, alcohol, energy intake, potassium, sodium, calcium, magnesium, fiber, carbohydrates, SFA, PUFA, |
|
| Beasley et al., 2010 (28) |
Prospective cohort | The Women's Health Imitative Observational Study (WHI-OS)24,417 non-frail women aged 65–79 y at baseline | Frailty score. |
Calibrated total, and animal protein intake expressed as E%, and g/kg BW and in quintiles | 122-item FFQ |
24,417 |
3 y | Protein intake expressed as uncalibrated, calibrated and in quintiles was inversely associated to frailty. |
Age, ethnicity, BMI, income, education, current health provider, smoking, alcohol, health status, history of comorbidity, hormone use, number of falls, living alone, ADL, depressive symptoms, calibrated energy intake, fat E%, supplement use | B | |
| Bates et al., 2010 |
Prospective cohort | The British National Diet and Nutrition Survey of people Aged 65 years and Over |
All-cause mortality from the National Health Service register | Protein intake in g/d | 4-d weighed dietary record. No further information about the dietary assessment method and its validation | 1,100 men and women | 14 y | HR 0.86 (95% CI: 0.77–0.97) | Only results for Age, sex, as confounders are shown |
|
|
1 exp Dietary Proteins/ (71799)
2 Proteins/me [Metabolism] (61274)
3 Nitrogen/me [Metabolism] (19039)
4 amino acids/ or exp amino acids, essential/ (266907)
5 exp Diet, Protein-Restricted/ or exp Diet, Vegetarian/ (3849)
6 exp Fish Proteins/ (7102)
7 exp Plant Proteins/ (112865)
8 ((egg* or yolk* or milk or animal* or diet*) adj3 protein*).tw. (30205)
9 (amino adj2 acid* adj4 (essential* or nonessential* or non essential* or dispensable* or nondispensable* or non dispensable*)).tw. (6328)
10 (diet* adj3 (low protein* or protein restricted or protein free or high protein)).tw. (5813)
11 ((Soy or soy bean* or soybean* or plant or vegetable* or fish) adj3 protein*).tw. (10738)
12 ((vegan* or vegetarian*) and protein*).tw. (444)
13 ((diet* or balance*) adj3 nitrogen*).tw. (4906)
14 or/1–13 (528777)
15 (intake* or timing* or frequen* or requirement* or utilization*).tw. (1384587)
16 nutritional requirements/ (15722)
17 15 or 16 (1392935)
18 14 and 17 (48263)
19 exp Lipids/bl [Blood] (164517)
20 exp Lipoproteins/ (107523)
21 exp Hyperlipidemias/ (50696)
22 cholesterol, hdl/ or cholesterol, ldl/ (27190)
23 exp Triglycerides/ (55871)
24 ((serum or blood) adj2 lipid*).tw. (21078)
25 lipoprotein*.tw. (95533)
26 hyperlipidemia*.tw. (12571)
27 (cholesterol adj2 (hdl or ldl)).tw. (35090)
28 triglyceride*.tw. (63777)
29 or/19–27 (281777)
30 exp Glucose/ (215099)
31 exp Hyperglycemia/ (20648)
32 (glucose or dextrose).tw. (280143)
33 (d glucose or l glucose).tw. (16987)
34 (fasting adj3 glucose).tw. (18392)
35 (hyperglycemia or hyperglucemia or hyperglycemic or (hyper adj glycemi*)).tw. (25219)
36 (blood adj2 (sugar or glucose)).tw. (43161)
37 (glucose adj2 intoleranc*).tw. (5750)
38 or/30–37 (370848)
39 Insulin/ (142600)
40 exp Insulin Resistance/ (38231)
41 exp Hyperinsulinism/ (43180)
42 (humulin or iletin or insulin or novolin or velosulin).tw. (226819)
43 (hyperinsulin* or insulinem*).tw. (18338)
44 (insulin adj2 (sensitiv* or resistanc* or hypersensitiv*)).tw. (46353)
45 or/39–44 (270838)
46 exp Blood Pressure/ (226330)
47 exp hypertension/ (188397)
48 exp hypotension/ (21099)
49 ((blood or diastolic* or pulse or systolic*) adj2 pressur*).tw. (211754)
50 (hypertension* or hypotension*).tw. (263275)
51 or/46–49 (453970)
52 exp Body Composition/ (28527)
53 exp body mass index/ (56123)
54 exp Abdominal Fat/ (2418)
55 Waist–hip ratio/ (2052)
56 exp Adipose Tissue/ (59986)
57 (body adj2 composition*).tw. (16839)
58 (body adj2 fat* adj3 (distribution* or pattern*)).tw. (2312)
59 (body adj2 mass adj3 index).tw. (68249)
60 bmi.tw. (46648)
61 ((fat free or lean) adj3 body mass).tw. (5098)
62 (waist adj2 hip).tw. (6197)
63 adiposity.tw. (9077)
64 ((visceral or abdominal or body or pad) adj2 fat*).tw. (28631)
65 or/52–64 (192342)
66 exp “Bone and Bones”/ (429468)
67 Bone Density/ (33081)
68 exp Fractures, Bone/ (124402)
69 exp Osteoporosis/ (38044)
70 (bone or bones).tw. (430056)
71 (osteoporos* or bone loss*).tw. (47186)
72 or/66–71 (802479)
73 exp Pregnancy Outcome/ (32312)
74 exp Parturition/ (5980)
75 Abortion, Spontaneous/ (12901)
76 exp Infant, Newborn/ (447494)
77 “growth and development”/ or exp aging/ or exp growth/ (673749)
78 exp Muscular Atrophy/ (7784)
79 (birth* or childbirth* or stillbirth* or (pregnancy adj2 outcome*)).tw. (212641)
80 parturition*.tw. (10663)
81 (abortion* or miscarriage*).tw. (47509)
82 ((Infant* adj2 newborn) or neonate*).tw. (74510)
83 (Body adj2 (size or height* or weight*)).tw. (142288)
84 (cell* adj2 (growth or enlargement* or proliferation*)).tw. (182400)
85 (organ adj2 (size* or weight* or volume*)).tw. (4629)
86 (development* adj2 (human* or child* or infant* or adolescent*)).tw. (26608)
87 (aging or ageing or longevity).tw. (117701)
88 ((muscular adj2 atrop*) or sarcopenia).tw. (5675)
89 or/73–88 (1537884)
90 exp Body Weight/ (291817)
91 ((birth or body or fetal or gain or los* or reduc* or decreas* or chang*) adj2 weight*).tw. (232690)
92 (obesit* or obese or leanness or thinness or underweight or under weight or overweight or over weight).tw. (134236)
93 (emaciation* or cachexia).tw. (5111)
94 or/90–93 (473911)
95 Cardiovascular Diseases/ (77121)
96 exp heart diseases/ (772950)
97 exp vascular diseases/ (1159229)
98 (cardio* or cardia* or heart* or vascular* or ischem* or ischeam* or coronary* or myocardial* or angina* or cvd or chd or arrythmi* or atrial* or endocardi* or fibrillate*).tw. (1595528)
99 (vascular* or thromboembolism* or thrombosis*).tw. (451761)
100 or/95–99 (2391038)
101 exp neoplasms/ (2199022)
102 (cancer* or tumor* or carcinoma* or neoplasm*).tw. (1573780)
103 or/101–102 (2505578)
104 exp Diabetes Mellitus, Type 2/ (63869)
105 exp Insulin Resistance/ (38231)
106 ((typ* 2 or typ* ii) adj diabet*).tw. (51164)
107 impaired glucose toleranc*.tw. (6845)
108 glucose intoleranc*.tw. (5714)
109 insulin resistanc*.tw. (36244)
110 (MODY or NIDDM or T2DM or DM 2).tw. (10504)
111 ((non insulin* or noninsulin*) adj2 depend*).tw. (11937)
112 (non insulin?depend* or noninsulin?depend*).tw. (18)
113 ((keto restist* or non keto* or nonketo*) adj2 diabet*).tw. (346)
114 ((adult* or matur* or late or slow or stabl*) adj2 diabet*).tw. (5486)
115 (insulin defic* adj2 relativ*).tw. (126)
116 plur?metabolic* syndrome*.tw. (32)
117 or/104–115 (128394)
118 exp diabetes insipidus/ (6512)
119 diabet* insipidus.tw. (6199)
120 or/118–119 (8185)
121 117 not 120 (128330)
122 Interleukin-6/ (35767)
123 exp receptors, interleukin-6/ (2773)
124 c-reactive protein/ (22323)
125 tumor necrosis factor-alpha/ (79154)
126 Cytokines/ (79501)
127 exp lymphocytes/ (390817)
128 (interleukin 6 or IL 6 or IL6).tw. (58213)
129 (interleukin* adj2 (b or hp1)).tw. (227)
130 ((plasmacytoma or hybridoma) adj2 growth factor*).tw. (97)
131 (b cell adj2 (differentiat* or stimulat*)).tw. (4462)
132 (hepatocyte adj2 stimulat*).tw. (485)
133 ((beta2 or beta 2) adj2 interferon*).tw. (133)
134 (hepatocyte adj2 stimulat*).tw. (485)
135 (b adj lymphocyte*).tw. (25416)
136 (BSF?2 or IFN?beta?2 or MGI?2).tw. (56)
137 (BSF 2 or IFN beta 2 or MGI 2).tw. (242)
138 (myeloid adj3 protein).tw. (449)
139 ((26k or 26 k) adj2 protein*).tw. (36)
140 ((((il6 or il 6) adj soluble*) or (sil6r or sil 6 r or il6r or il 6 r or interleukin 6 receptor)) adj4 protein*).tw. (56)
141 (hsCRP or CRP).tw. (20078)
142 cd126.tw. (51)
143 (high sensitiv* adj3 c reactive protein*).tw. (3292)
144 cachectin*.tw. (447)
145 (Tnfalpha or tnf alpha*).tw. (70756)
146 tumor necrosis*.tw. (69922)
147 Tnf superfamily*.tw. (493)
148 (lymphocyte* or ((lymphoid* or killer) adj2 cell*)).tw. (282046)
149 or/122–148 (675867)
150 exp Kidney Diseases/ (358584)
151 exp Renal Circulation/ (11422)
152 (((kidney* or renal*) adj2 (calculi or calculus or stone*)) or nephrolithiasis).tw. (9918)
153 ((kidney* or renal*) adj2 (disease* or function*)).tw. (114942)
154 (renal adj3 (flow* or circulat*)).tw. (13708)
155 or/150–154 (418863)
156 exp Muscle Strength/ (10755)
157 Muscle Fatigue/ (4587)
158 exp Physical Endurance/ (19718)
159 exp Exercise/ (54191)
160 Physical fitness/ (18227)
161 exp Motor Activity/ (93817)
162 ((muscle or muscular) adj2 (strength* or fatigue* or weak*)).tw. (22245)
163 (physical* adj2 (fitness or exercise* or active or activity or endur*)).tw. (50835)
164 ((train* or exercise*) adj2 endur*).tw. (6383)
165 or/156–164 (218608)
166 Mortality/ (30837)
167 mortal*.tw. (358222)
168 ((fatalit* or death*) adj2 rate*).tw. (21676)
169 (excess adj2 mortalit*).tw. (3980)
170 or/166–169 (382939)
171 exp Lactation/ (29877)
172 Milk, human/ (13700)
173 breast feeding/ (22118)
174 lactation*.tw. (23492)
175 (milk adj2 (human* or breast*)).tw. (13617)
176 (breast feed* or breastfeed*).tw. (19668)
177 or/171–176 (74168)
178 18 and 29 (2069)
179 18 and 38 (4390)
180 18 and 45 (2751)
181 18 and 51 (1153)
182 18 and 65 (3577)
183 18 and 72 (1449)
184 18 and 89 (12410)
185 18 and 94 (9635)
186 18 and 100 (3007)
187 18 and 103 (3541)
188 18 and 121 (863)
189 18 and 149 (2860)
190 18 and 155 (2096)
191 18 and 165 (1243)
192 18 and 170 (901)
193 18 and 177 (2680)
194 or/178–193 (26444)
195 limit 194 to (humans and yr=“2000–Current”) (6022)
196 limit 195 to English language (5632)
197 limit 196 to “reviews (sensitivity)” (3153)